Quantitative Method for the Analysis of Ivacaftor, Hydroxymethyl Ivacaftor, Ivacaftor Carboxylate, Lumacaftor, and Tezacaftor in Plasma and Sputum Using Liquid Chromatography With Tandem Mass Spectrometry and Its Clinical Applicability-Reference-Cited by-同舟云学术

Quantitative Method for the Analysis of Ivacaftor, Hydroxymethyl Ivacaftor, Ivacaftor Carboxylate, Lumacaftor, and Tezacaftor in Plasma and Sputum Using Liquid Chromatography With Tandem Mass Spectrometry and Its Clinical Applicability

Published:2021-08 Issue:4 Volume:43 Page:555-563
ISSN:0163-4356
Container-title:Therapeutic Drug Monitoring
language:en
Short-container-title:

Author:

Vonk Steffie E. M.,van der Meer-Vos Marloes,Bos Lieuwe D. J.,Neerincx Anne H.,Majoor Christof J.,Maitland-van der Zee Anke-Hilse,Mathôt Ron A. A.,Kemper E. Marleen

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Pharmacology

Reference19 articles.

1. Cystic fibrosis;Elborn;Lancet.,2016

2. Cystic fibrosis: a disease of vulnerability to airway surface dehydration;Boucher;Trends Mol Med.,2007

3. CFTR expression and organ damage in cystic fibrosis;Tizzano;Ann Intern Med.,1995

4. Can cystic fibrosis patients finally catch a breath with lumacaftor/ivacaftor?;Schneider;Clin Pharmacol Ther.,2017

5. Efficacy and safety of lumacaftor and ivacaftor in patients aged 6-11 years with cystic fibrosis homozygous for F508del-CFTR: a randomised, placebo-controlled phase 3 trial;Ratjen;Lancet Respir Med.,2017

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Differential distribution of ivacaftor and its metabolites in plasma and human airway epithelia;Pulmonary Pharmacology & Therapeutics;2024-09

2. A rapid LC-MS/MS method for the simultaneous quantification of ivacaftor, lumacaftor, elexacaftor, tezacaftor, hexyl-methyl ivacaftor and ivacaftor carboxylate in human plasma;Journal of Pharmaceutical and Biomedical Analysis;2024-09

3. Development and clinical implementation of an LC-HRMS method for ivacaftor, lumacaftor, tezacaftor and elexacaftor in human plasma and breast milk;Analytical and Bioanalytical Chemistry;2024-08-28

4. Dried Blood Spot Method Development and Clinical Validation for the Analysis of Elexacaftor, Elexacaftor-M23, Tezacaftor, Tezacaftor-M1, Ivacaftor, Ivacaftor Carboxylate, and Hydroxymethyl Ivacaftor Using LC-MS/MS;Therapeutic Drug Monitoring;2024-08-27

5. HPLC method for simultaneous quantification of lumacaftor and ivacaftor bulk and pharmaceutical formulations;European Journal of Life Sciences;2023-12-29